TBC/LysM-associated domain-containing 2 (TBC1D2) is a protein encoded by the TBC1D2 gene in humans. This protein belongs to the TBC (Tre-2/Bub2/Cdc16) domain family, which is known for its role in regulating cell signaling pathways, particularly those associated with membrane trafficking and signal transduction. The TBC domain typically functions as a GTPase-activating protein (GAP) for small GTPases of the Rab family, which are key regulators of vesicle trafficking in eukaryotic cells.The TBC1D2 protein is characterized by the presence of a TBC domain and a LysM (Lysin motif) domain. The LysM domain is often associated with bacterial cell wall degradation and has been implicated in peptidoglycan binding, suggesting a potential role in recognizing or interacting with carbohydrate moieties. This combination of domains within TBC1D2 suggests a unique function that may bridge membrane trafficking with specific molecular recognition processes.
Although the precise cellular functions of TBC1D2 are not fully understood, the protein is thought to participate in the regulation of membrane dynamics and signal transduction pathways. By acting on Rab GTPases, TBC1D2 could influence vesicular transport pathways, including endocytosis and exocytosis, which are vital for maintaining cellular homeostasis, nutrient uptake, and signal dissemination.TBC1D2's involvement in such fundamental processes makes it a subject of interest in the study of cellular logistics and communication. Dysregulation of these pathways could have significant consequences, potentially leading to a variety of cellular dysfunctions or diseases.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which is involved in cell growth and metabolism, and may indirectly influence TBC1D2. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMP-activated protein kinase (AMPK) and may impact TBC1D2 through metabolic pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K) and might affect TBC1D2 by modulating PI3K/AKT signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, a key component of the MAPK/ERK pathway, potentially affecting TBC1D2. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA, an inhibitor of histone deacetylases, impacts gene expression and chromatin remodeling, potentially influencing TBC1D2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, another PI3K inhibitor, could affect TBC1D2 activity by modulating PI3K/AKT signaling. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone, a PPAR-gamma agonist, affects glucose metabolism and insulin sensitivity, potentially influencing TBC1D2. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, with anti-inflammatory and antioxidant properties, might impact TBC1D2 indirectly through these mechanisms. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, could influence TBC1D2 activity by affecting stress response pathways. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose, a glycolysis inhibitor, might affect TBC1D2 through metabolic stress pathways. | ||||||